Published in Int J Cancer on September 20, 2004
Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2007) 7.08
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73
How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst (2014) 3.43
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int (2009) 2.61
The metabolic syndrome: A high-risk state for cancer? Am J Pathol (2006) 2.46
Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res (2009) 2.23
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) (2012) 1.63
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res (2010) 1.51
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat (2011) 1.47
Genome-wide association study of height and body mass index in Australian twin families. Twin Res Hum Genet (2010) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Male breast carcinoma: increased awareness needed. Breast Cancer Res (2011) 1.40
Weight management and its role in breast cancer rehabilitation. Cancer (2012) 1.39
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res (2012) 1.37
A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev (2010) 1.34
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Association of Rotating Night Shift Work with BMI and Abdominal Obesity among Nurses and Midwives. PLoS One (2015) 1.25
Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes (2011) 1.23
The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol (2011) 1.21
A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control (2013) 1.17
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17
Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab (2013) 1.11
Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer (2009) 1.07
Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol (2011) 1.06
Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control (2012) 1.05
The prevalence and correlates of breast cancer among women in Eastern China. PLoS One (2012) 1.05
Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer (2010) 1.03
Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol (2008) 1.02
Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer (2012) 1.02
Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst (2010) 0.99
Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98
Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol (2014) 0.98
Case-control study of body size and breast cancer risk in Nigerian women. Am J Epidemiol (2010) 0.98
Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res (2005) 0.96
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation. Hum Genet (2007) 0.94
Role of obesity in the risk of breast cancer: lessons from anthropometry. J Oncol (2013) 0.94
Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat (2011) 0.93
Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol (2014) 0.91
Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin Exp Metastasis (2010) 0.91
An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk. Comput Math Methods Med (2012) 0.91
Exogenous and endogenous hormones and breast cancer. Best Pract Res Clin Endocrinol Metab (2008) 0.91
Overall and central adiposity and breast cancer risk in the sister study. Cancer (2015) 0.90
Obesity-related markers and breast cancer in CPS-II Nutrition Cohort. Int J Mol Epidemiol Genet (2013) 0.90
Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles. Cancer (2011) 0.90
Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia (2013) 0.90
Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.90
Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer. PLoS One (2012) 0.89
Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr (2007) 0.89
Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res (Phila) (2011) 0.89
Leptin levels and leptin receptor polymorphism frequency in healthy populations. Infect Agent Cancer (2009) 0.89
Obesity/weight gain and breast cancer risk: findings from the Japan collaborative cohort study for the evaluation of cancer risk. J Epidemiol (2013) 0.89
Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res (2015) 0.89
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Med (2016) 0.87
Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.87
The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res (2010) 0.87
Circulatory estrogen level protects against breast cancer in obese women. Recent Pat Anticancer Drug Discov (2013) 0.86
Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) (2014) 0.86
Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus (2013) 0.86
Cell density-dependent transcriptional activation of endocrine-related genes in human adipose tissue-derived stem cells. Exp Cell Res (2010) 0.86
Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis. Oncol Lett (2014) 0.85
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo. J Cell Mol Med (2015) 0.84
Early breast cancer. Int J Clin Oncol (2006) 0.84
Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study. Cancer Causes Control (2012) 0.84
Lifestyle changes for prevention of breast cancer. Electron Physician (2014) 0.84
Leg length, sitting height and postmenopausal breast cancer risk. Br J Cancer (2012) 0.83
Obesity in post menopausal women with a family history of breast cancer: prevalence and risk awareness. Int Semin Surg Oncol (2009) 0.82
Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study. J Womens Health (Larchmt) (2015) 0.82
Weight change in adulthood and risk of postmenopausal breast cancer: the HUNT study of Norway. Br J Cancer (2013) 0.82
Cardiometabolic factors and breast cancer risk in U.S. black women. Breast Cancer Res Treat (2012) 0.82
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. Cancer Epidemiol Biomarkers Prev (2015) 0.81
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor. Breast Cancer Res Treat (2011) 0.81
Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol (2013) 0.81
Improving the management of people with a family history of breast cancer in primary care: before and after study of audit-based education. BMC Fam Pract (2013) 0.80
Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers. Dis Markers (2015) 0.80
Impact of body mass index on breast cancer in accordance with the life-stage of women. Front Oncol (2012) 0.80
Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk. Clin Cancer Res (2014) 0.80
Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study. Fam Cancer (2007) 0.80
Susceptibility variants for waist size in relation to abdominal, visceral, and hepatic adiposity in postmenopausal women. J Acad Nutr Diet (2012) 0.79
Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity. J Cell Mol Med (2009) 0.79
Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages. Oncotarget (2016) 0.79
Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study. Br J Cancer (2015) 0.79
Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study. Breast Cancer Res (2006) 0.79
Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMJ Open (2014) 0.79
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women. Breast Cancer Res (2014) 0.79
Lipid profile among Moroccan overweight women and breast cancer: a case-control study. Int J Gen Med (2013) 0.79
Emerging Concepts in Breast Cancer Risk Prediction. Curr Obstet Gynecol Rep (2013) 0.78
Regression analysis with categorized regression calibrated exposure: some interesting findings. Emerg Themes Epidemiol (2006) 0.78
Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia. J Oncol (2012) 0.78
ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity. Cancer Causes Control (2012) 0.78
The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort. Breast Cancer Res (2015) 0.78
Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China. World J Surg Oncol (2013) 0.77
Serum selenium level and other risk factors for breast cancer among patients in a Malaysian hospital. Environ Health Prev Med (2007) 0.77
Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study. J Negat Results Biomed (2014) 0.77
The Obesity-Breast Cancer Conundrum: An Analysis of the Issues. Int J Mol Sci (2016) 0.76
Associations between Obesity, Body Fat Distribution, Weight Loss and Weight Cycling on Serum Pesticide Concentrations. J Food Nutr Disord (2016) 0.76
MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study. Nutr Cancer (2015) 0.76
Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics. BMC Cancer (2015) 0.76
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med (2003) 11.58
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum (2003) 10.65
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med (2008) 9.83
Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med (2008) 8.70
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med (2004) 8.36
Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol (2003) 8.25
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol (2003) 7.68
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18
Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr (2002) 7.01
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
LDL-cholesterol concentrations: a genome-wide association study. Lancet (2008) 6.44
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation (2006) 6.17
Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med (2008) 6.14
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst (2008) 5.64
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA (2009) 5.52
Fruit, vegetables, and olive oil and risk of coronary heart disease in Italian women: the EPICOR Study. Am J Clin Nutr (2010) 5.50
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet (2005) 5.20
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest (2007) 5.02
Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ (2009) 4.99
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ (2010) 4.92
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89